{"id":2986,"date":"2026-10-06T13:10:17","date_gmt":"2026-10-06T13:10:17","guid":{"rendered":"https:\/\/nanomnia.eu\/?p=2986"},"modified":"2026-10-06T13:34:19","modified_gmt":"2026-10-06T13:34:19","slug":"nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough","status":"publish","type":"post","link":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/","title":{"rendered":"NANOENCAPSULATION FOR DRUG DELIVERY: when the molecule is not enough"},"content":{"rendered":"\n

Curcumin has been used in traditional medicine for thousands of years. It shows measurable anti-inflammatory and antioxidant activity in the lab. And yet, when you swallow it as a supplement, almost none of it reaches your bloodstream in a form your body can actually use. The molecule is there. The problem is getting it where it needs to go.<\/p>\n\n\n\n

This gap between what a compound can do and what it actually does inside the body is one of the central challenges in modern drug development and nutraceutical science. Many of the most promising molecules, whether synthesised  in a laboratory or extracted from a plant, fail not because they lack efficacy but because they cannot survive the journey to their target. Nanoencapsulation in pharmacy<\/a> was developed, to solve this problem.<\/p>\n\n\n\n

NANOENCAPSULATION FOR DRUG DELIVERY<\/strong><\/h2>\n\n\n\n

When a drug or bioactive compound is taken orally, it faces a series of obstacles before it can do its job. The acidic environment of the stomach can break it down before it reaches the small intestine. The intestinal wall itself limits which molecules can pass through and into the bloodstream. Whatever does make it through then passes directly to the liver, which filters out a significant portion of the compound before it ever reaches general circulation. This combination of intestinal  degradation and liver metabolism is known as the first-pass effect, and it is why the dose you take is almost never the dose that acts.<\/p>\n\n\n\n

Injectable drugs avoid the intestine  entirely, but they then face different barriers. The bloodstream is an aggressive environment. Proteins in the plasma can bind to a drug molecule and neutralize it. The kidneys filter out small molecules quickly. And for drugs targeting the brain, there is the blood-brain barrier, a tightly controlled membrane that blocks almost everything that has not been specifically designed to cross it.<\/p>\n\n\n\n

Nanoencapsulation changes the equation. By wrapping an active molecule inside a carrier particle, typically between 50 and 500 nanometres in diameter, the formulation protects the compound from degradation, controls when and where it is released, and in some cases actively directs it toward specific tissues. The carrier is not just packaging. It is part of the therapeutic design.<\/p>\n\n\n\n

NANOENCAPSULATION TECHNOLOGY<\/strong><\/h2>\n\n\n\n

The field has developed several distinct carrier platforms, each suited to different types of molecules and delivery challenges. Understanding the differences between them is not academic: the choice of carrier has direct consequences for how a drug behaves in the body, how long it lasts, and where it ends up.<\/p>\n\n\n\n

Liposomes are among the oldest and best-established technologies. They are spherical vesicles made of phospholipid bilayers, the same material that forms cell membranes, which makes them inherently compatible with biological tissue. A liposome can carry water-soluble compounds in its aqueous core and fat-soluble compounds within its lipid membrane. Doxil, approved by the FDA in 1995 as the first nanomedicine to reach the market, uses liposomes to deliver doxorubicin, a chemotherapy agent, with a markedly different distribution profile than the free drug, reducing the cardiac toxicity that had long limited its use.<\/p>\n\n\n\n

Solid lipid nanoparticles offer a more stable alternative. Rather than a liquid lipid core, they use fats that are solid at body temperature, which slows the release of the encapsulated compound and improves shelf life. Polymeric nanoparticles, made from materials such as PLGA (poly lactic-co-glycolic acid), a biodegradable polymer already well established in medical implants, allow for very precise control of release kinetics and can be designed to degrade over days, weeks, or months depending on the formulation.<\/p>\n\n\n\n

Nanoemulsions are fine droplets of oil dispersed in water (or the reverse), stabilized by surfactants. They are widely used in cosmetics and topical pharmaceutical products because they penetrate the skin more effectively than conventional creams and can carry both hydrophilic and hydrophobic active ingredients  in a single formulation.<\/p>\n\n\n\n

Albumin nanoparticles represent a newer but increasingly important category. Albumin is the most abundant protein in human blood plasma, and the body handles it as a natural carrier molecule. Nanoparticles built around albumin are inherently biocompatible and tend to accumulate in tumour tissue due to the enhanced permeability and retention effect, a phenomenon where leaky tumour vasculature allows nanoparticles to pass through and accumulate at the target site. This makes albumin-based carriers particularly attractive for oncology applications.<\/p>\n\n\n\n

What these platforms share is the ability to take a molecule that would otherwise be limited by its own physical and chemical properties and give it a better set of delivery characteristics, without changing the molecule itself. The choice of carrier depends on the active compound’s solubility, the desired release profile, the route of administration, and the target tissue, and it is this matching of carrier to compound and context that sits at the core of modern formulation science.<\/p>\n\n\n\n

NANOENCAPSULATION OF PLANT EXTRACTS<\/strong><\/h2>\n\n\n\n

Some of the clearest examples of nanoencapsulation in practice come from molecules that originate in plants. These natural compounds often show strong biological activity but poor stability or bioavailability, making them natural candidates for encapsulation. Three examples span the sectors most relevant to this  technology today.<\/p>\n\n\n\n

In pharmaceutical medicine, one of the most cited cases is paclitaxel, the active compound extracted from the bark of Taxus brevifolia<\/em>, the Pacific yew tree. Paclitaxel is a powerful chemotherapy agent that disrupts cell division in rapidly growing tumours. For decades, its clinical use was complicated by its near-insolubility in water. Formulating it required dissolving it in Cremophor EL, a castor oil derivative, which caused serious hypersensitivity reactions in many patients and required premedication and slow infusion protocols. In 2005, the FDA approved Abraxane, a formulation in which paclitaxel is bound to albumin nanoparticles of approximately 130 nanometres. The albumin shell dissolves rapidly in the bloodstream, releasing the drug in a form the body handles far more naturally than the solvent-based version. Abraxane does not require Cremophor EL, shortens infusion time, and has since been approved for breast cancer, non-small-cell lung cancer, and pancreatic cancer. The molecule did not change. The delivery system did.<\/p>\n\n\n\n

In nutraceutical science, curcumin has become something of a test case for the entire field. Extracted from the root of Curcuma longa<\/em>, the plant behind the spice turmeric, curcumin has been studied extensively for its anti-inflammatory and antioxidant properties. The challenge is that it is highly insoluble in water and is rapidly metabolised  before it can be absorbed in significant quantities. Clinical trials with free curcumin have repeatedly shown that very little of what is ingested actually reaches systemic circulation. A randomised  clinical trial published in Scientific Reports in 2026 compared free curcumin with a liposomal curcumin formulation and found the encapsulated version produced blood levels approximately 23 times higher. The liposome protects the molecule through the digestive tract and improves its uptake through the intestinal wall, giving the body access to what the compound can actually do rather than what it promises on paper.<\/p>\n\n\n\n

In cosmetics, essential oils are extracted from aromatic plants including lavender, eucalyptus, tea tree, and rose, and used both for fragrance and for documented skin benefits. They are also among the most volatile and chemically unstable ingredients in a cosmetic formulation. Exposed to air, light, and heat, they oxidise  and degrade. Applied directly to skin at higher concentrations, some cause irritation or sensitization. Encapsulated in nanoemulsions or polymeric shells, the same oils become stable over the shelf life of the product, release more gradually on the skin, and can be incorporated at concentrations that would otherwise be problematic. A moisturiser that releases a skin-active essential oil slowly over several hours delivers something fundamentally different from one that deposits the same oil in a single burst on first contact.<\/p>\n\n\n\n

WHERE THIS IS HEADING<\/strong><\/h2>\n\n\n\n

Regulatory frameworks for nanomaterials in pharmaceutical and food applications are continuously developing . The FDA’s guidance on nanomaterials in drug products and the European Food Safety Authority’s framework for nanotechnologies in food and feed both reflect the understanding that particle size affects how a substance behaves in the body, and that safety assessments need to account for this. The direction is toward greater specificity: not just what a compound is, but how it is formulated and what that formulation does to its behaviour in a biological system.<\/p>\n\n\n\n

For nutraceuticals and cosmetics, the European Commission’s revision of the Novel Food Regulation and ongoing work by the Scientific Committee on Consumer Safety continue to refine how nanomaterials are evaluated, with particular attention to carrier systems that alter absorption profiles. The trend in all these sectors is the same: regulators are asking more precise questions, and the industry needs more precise formulation science to answer them.<\/p>\n\n\n\n

Nanomnia works at this intersection, developing encapsulation systems for pharmaceutical, nutraceutical, and cosmetic applications where the challenge is not just finding the right active compound but building the right system to deliver it. The curcumin and paclitaxel cases are examples of what becomes possible when formulation science catches up with the molecule’s potential. The next generation of plant-derived and synthetic active ingredients  will likely follow the same pattern.<\/p>\n\n\n\n

CONCLUSION<\/strong><\/h2>\n\n\n\n

The curcumin paradox is not unique to curcumin. Across pharmaceutical, nutraceutical, and cosmetic applications, there is a long list of compounds with well-documented activity and poor real-world performance due to solubility, stability, or absorption problems. Nanoencapsulation does not create new molecules. It creates the conditions under which existing molecules can finally do what they were always capable of.<\/p>\n\n\n\n

Abraxane made paclitaxel from the Pacific yew tree clinically manageable for a far broader range of patients. Liposomal curcumin turned a theoretical anti-inflammatory into something the body can actually absorb. Encapsulated essential oils became stable, controlled-release cosmetic ingredients rather than volatile, irritation-prone additives. In each case, the breakthrough was not in the active ingredient. It was in the engineering that carried it.<\/p>\n\n\n\n

\n
NANOENCAPSULATION IN PHARMACY<\/a><\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Curcumin has been used in traditional medicine for thousands of years. It shows measurable anti-inflammatory and antioxidant activity in the lab. And yet, when you swallow it as a supplement, almost none of it reaches your bloodstream in a form your body can actually use. The molecule is there. The problem is getting it where it needs to go. This … <\/p>\n

Read More<\/a><\/div>\n","protected":false},"author":4,"featured_media":2991,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","footnotes":""},"categories":[29,29],"tags":[],"class_list":["post-2986","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\nNano encapsulation for drug delivery | Nanomnia<\/title>\n<meta name=\"description\" content=\"The use of nanoencapsulation for drug delivery is very important to preserve the active ingredient of drugs through the digestive tract\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nano encapsulation for drug delivery | Nanomnia\" \/>\n<meta property=\"og:description\" content=\"The use of nanoencapsulation for drug delivery is very important to preserve the active ingredient of drugs through the digestive tract\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanomnia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/NanomniaSrl\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-06T13:10:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-06T13:34:19+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/nanomnia.eu\/wp-content\/uploads\/2026\/10\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"gestione.sito\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"gestione.sito\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/\"},\"author\":{\"name\":\"gestione.sito\",\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/#\\\/schema\\\/person\\\/aa4775fba1cd223038d8b1b2898afce4\"},\"headline\":\"NANOENCAPSULATION FOR DRUG DELIVERY: when the molecule is not enough\",\"datePublished\":\"2026-10-06T13:10:17+00:00\",\"dateModified\":\"2026-10-06T13:34:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/\"},\"wordCount\":1630,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanomnia.eu\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg\",\"articleSection\":[\"News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/\",\"url\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/\",\"name\":\"Nano encapsulation for drug delivery | Nanomnia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanomnia.eu\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg\",\"datePublished\":\"2026-10-06T13:10:17+00:00\",\"dateModified\":\"2026-10-06T13:34:19+00:00\",\"description\":\"The use of nanoencapsulation for drug delivery is very important to preserve the active ingredient of drugs through the digestive tract\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanomnia.eu\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg\",\"contentUrl\":\"https:\\\/\\\/nanomnia.eu\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NANOENCAPSULATION FOR DRUG DELIVERY: when the molecule is not enough\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/\",\"name\":\"Nanomnia\",\"description\":\"Size matters. The smaller, the better.\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/#organization\",\"name\":\"Nanomnia\",\"url\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/nanomnia.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/Component-1@2x.png\",\"contentUrl\":\"http:\\\/\\\/nanomnia.eu\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/Component-1@2x.png\",\"width\":777,\"height\":113,\"caption\":\"Nanomnia\"},\"image\":{\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/NanomniaSrl\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanomnia-srl\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCnSbR9GmjkcogoqIHn1WElQ\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/#\\\/schema\\\/person\\\/aa4775fba1cd223038d8b1b2898afce4\",\"name\":\"gestione.sito\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1b9e6b59b9a79b6c4b23161906f9c68077fcb9e48dfceb64d6d5037769cb2d85?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1b9e6b59b9a79b6c4b23161906f9c68077fcb9e48dfceb64d6d5037769cb2d85?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1b9e6b59b9a79b6c4b23161906f9c68077fcb9e48dfceb64d6d5037769cb2d85?s=96&d=mm&r=g\",\"caption\":\"gestione.sito\"},\"url\":\"https:\\\/\\\/nanomnia.eu\\\/en\\\/author\\\/gestione-sito\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nano encapsulation for drug delivery | Nanomnia","description":"The use of nanoencapsulation for drug delivery is very important to preserve the active ingredient of drugs through the digestive tract","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/","og_locale":"en_US","og_type":"article","og_title":"Nano encapsulation for drug delivery | Nanomnia","og_description":"The use of nanoencapsulation for drug delivery is very important to preserve the active ingredient of drugs through the digestive tract","og_url":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/","og_site_name":"Nanomnia","article_publisher":"https:\/\/www.facebook.com\/NanomniaSrl\/","article_published_time":"2026-10-06T13:10:17+00:00","article_modified_time":"2026-10-06T13:34:19+00:00","og_image":[{"width":1920,"height":1080,"url":"http:\/\/nanomnia.eu\/wp-content\/uploads\/2026\/10\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg","type":"image\/jpeg"}],"author":"gestione.sito","twitter_card":"summary_large_image","twitter_misc":{"Written by":"gestione.sito","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/#article","isPartOf":{"@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/"},"author":{"name":"gestione.sito","@id":"https:\/\/nanomnia.eu\/en\/#\/schema\/person\/aa4775fba1cd223038d8b1b2898afce4"},"headline":"NANOENCAPSULATION FOR DRUG DELIVERY: when the molecule is not enough","datePublished":"2026-10-06T13:10:17+00:00","dateModified":"2026-10-06T13:34:19+00:00","mainEntityOfPage":{"@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/"},"wordCount":1630,"commentCount":0,"publisher":{"@id":"https:\/\/nanomnia.eu\/en\/#organization"},"image":{"@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/#primaryimage"},"thumbnailUrl":"https:\/\/nanomnia.eu\/wp-content\/uploads\/2026\/10\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg","articleSection":["News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/","url":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/","name":"Nano encapsulation for drug delivery | Nanomnia","isPartOf":{"@id":"https:\/\/nanomnia.eu\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/#primaryimage"},"image":{"@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/#primaryimage"},"thumbnailUrl":"https:\/\/nanomnia.eu\/wp-content\/uploads\/2026\/10\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg","datePublished":"2026-10-06T13:10:17+00:00","dateModified":"2026-10-06T13:34:19+00:00","description":"The use of nanoencapsulation for drug delivery is very important to preserve the active ingredient of drugs through the digestive tract","breadcrumb":{"@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/#primaryimage","url":"https:\/\/nanomnia.eu\/wp-content\/uploads\/2026\/10\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg","contentUrl":"https:\/\/nanomnia.eu\/wp-content\/uploads\/2026\/10\/8_Nanomnia_Nanoencapsulation_Drug_Delivery-1.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/nanomnia.eu\/en\/nanoencapsulation-for-drug-delivery-when-the-molecule-is-not-enough\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanomnia.eu\/en\/home\/"},{"@type":"ListItem","position":2,"name":"NANOENCAPSULATION FOR DRUG DELIVERY: when the molecule is not enough"}]},{"@type":"WebSite","@id":"https:\/\/nanomnia.eu\/en\/#website","url":"https:\/\/nanomnia.eu\/en\/","name":"Nanomnia","description":"Size matters. The smaller, the better.","publisher":{"@id":"https:\/\/nanomnia.eu\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanomnia.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nanomnia.eu\/en\/#organization","name":"Nanomnia","url":"https:\/\/nanomnia.eu\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nanomnia.eu\/en\/#\/schema\/logo\/image\/","url":"http:\/\/nanomnia.eu\/wp-content\/uploads\/2019\/09\/Component-1@2x.png","contentUrl":"http:\/\/nanomnia.eu\/wp-content\/uploads\/2019\/09\/Component-1@2x.png","width":777,"height":113,"caption":"Nanomnia"},"image":{"@id":"https:\/\/nanomnia.eu\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/NanomniaSrl\/","https:\/\/www.linkedin.com\/company\/nanomnia-srl\/","https:\/\/www.youtube.com\/channel\/UCnSbR9GmjkcogoqIHn1WElQ"]},{"@type":"Person","@id":"https:\/\/nanomnia.eu\/en\/#\/schema\/person\/aa4775fba1cd223038d8b1b2898afce4","name":"gestione.sito","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1b9e6b59b9a79b6c4b23161906f9c68077fcb9e48dfceb64d6d5037769cb2d85?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1b9e6b59b9a79b6c4b23161906f9c68077fcb9e48dfceb64d6d5037769cb2d85?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1b9e6b59b9a79b6c4b23161906f9c68077fcb9e48dfceb64d6d5037769cb2d85?s=96&d=mm&r=g","caption":"gestione.sito"},"url":"https:\/\/nanomnia.eu\/en\/author\/gestione-sito\/"}]}},"_links":{"self":[{"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/posts\/2986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/comments?post=2986"}],"version-history":[{"count":2,"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/posts\/2986\/revisions"}],"predecessor-version":[{"id":2990,"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/posts\/2986\/revisions\/2990"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/media\/2991"}],"wp:attachment":[{"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/media?parent=2986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/categories?post=2986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanomnia.eu\/en\/wp-json\/wp\/v2\/tags?post=2986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}